Low In Vitro Production of Interferon-γ and Tumor Necrosis Factor-α in HIV-Seronegative Patients with Pulmonary Disease Caused by Nontuberculous Mycobacteria
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 20 (6) , 445-452
- https://doi.org/10.1023/a:1026407815946
Abstract
We studied 32 HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria (NTM). Immunologic studies included lymphocyte subset analysis by flow cytometry, measurement of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) production followingin vitro stimulation of diluted whole blood (DWB) and peripheral blood mononuclear cells (PBMC) by phytohemagglutinin (PHA), anti-CD3 as well as purified protein derivative of tuberculin (PPD), and in four cases with different amounts of the very mycobacterium, which caused disease in these patients. Data were compared to those of 30 HIV-seronegative patients with disease byMycobacterium tuberculosis (MTb). Following α-CD3-stimulation of PBMC, NTM patients showed lower IFN-γ(P < 0.00005) and lower TNF-α(P < 0.02). For a subgroup of tuberculin skin test-positive NTM patients we found significantly lower PPD-induced IFN-γ releases in cultured DWB(P < 0.0002) and PBMC(P < 0.0004) compared to MTb patients. Data for PPD-induced TNF-α release for this subgroup were also significant(P < 0.001 andP < 0.05, respectively). The four NTM patients with poor PPD-induced IFN-γ response hardly showed increased cytokine production on stimulation with their specific mycobacterium. The lower production capacity of IFN-γ and TNF-α of NTM patients compared to the MTb patients points to an immunologic imbalance forming the basis for their increased susceptibility to pulmonary infections by nontuberculous mycobacteria.Keywords
This publication has 32 references indexed in Scilit:
- Comparison between a Whole Blood Interferon?? Release Assay and Tuberculin Skin Testing for the Detection of Tuberculosis Infection among Patients at Risk for Tuberculosis ExposureThe Journal of Infectious Diseases, 1999
- Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteriaImmunology Today, 1998
- Clinical Correlates of Interferon Production in Patients with TuberculosisClinical Infectious Diseases, 1997
- A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial InfectionNew England Journal of Medicine, 1996
- Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.The Journal of Experimental Medicine, 1993
- Do CD2 and CD3-TCR T-cell activation pathways function independently?Immunology Today, 1990
- Infection withMycobacterium aviumComplex in Patients without Predisposing ConditionsNew England Journal of Medicine, 1989
- The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infectionCell, 1989
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983
- Indomethacin-responsive mononuclear cell dysfunction in “atypical” mycobacteriosisCellular Immunology, 1982